Yahoo Web Search

Search results

1. • Small Business - Picayune Item | Picayune Item

     The Picayune Item· 2 hours ago

     NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged

2. • 

     European Commission approves Biogen’s QALSODY for ALS treatment

     Pharmaceutical Technology via Yahoo Finance· 6 days ago

     The European Commission (EC) has granted marketing authorisation for Biogen's QALSODY (tofersen) an...

3. • INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on...

     Morningstar· 6 days ago

     Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) securities between ...

4. • 

     European Commission grants marketing approval to Biogen's ALS drug

     Reuters via Yahoo News· 6 days ago

     The approval is based on a 108-patient trial that showed Qalsody reduced levels of a neurofilament...

5. • 

     Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder

     Benzinga via Yahoo Finance· 5 days ago

     On Thursday, the European Commission granted marketing authorization under exceptional circumstances...

6. • Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors

     Guru Focus· 5 days ago

     Long-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth, and valuation ...

7. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 4 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) ...

8. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 3 days ago

     Captioned Gray v. Biogen Inc., No. 24-cv-01444 (D. Colo.), the Biogen class action lawsuit charges Biogen as well as certain of Biogen’s top current and ...

9. • 

     Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

     Zacks via Yahoo Finance· 5 days ago

     Biogen’s stock was up 2.6% on Thursday in response to Qalsody’s approval in the EU. Biogen’s stock...

10. • Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...

      Morningstar· 6 days ago

      Biogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for QALSODY® (tofersen ...